Andreea O. Lungu

1.4k total citations
16 papers, 1.1k citations indexed

About

Andreea O. Lungu is a scholar working on Molecular Biology, Epidemiology and Physiology. According to data from OpenAlex, Andreea O. Lungu has authored 16 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 3 papers in Epidemiology and 3 papers in Physiology. Recurrent topics in Andreea O. Lungu's work include Nuclear Structure and Function (5 papers), Diabetes and associated disorders (3 papers) and Adipose Tissue and Metabolism (2 papers). Andreea O. Lungu is often cited by papers focused on Nuclear Structure and Function (5 papers), Diabetes and associated disorders (3 papers) and Adipose Tissue and Metabolism (2 papers). Andreea O. Lungu collaborates with scholars based in United States, Romania and Spain. Andreea O. Lungu's co-authors include Bradford C. Berk, Zheng‐Gen Jin, Tatsuo Tanimoto, Phillip Görden, Hiroto Ueba, Mary D. Frame, Chelsea Wong, Elaine Cochran, Meng Wang and Liang Xie and has published in prestigious journals such as Journal of Biological Chemistry, Circulation Research and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Andreea O. Lungu

16 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andreea O. Lungu United States 11 641 221 146 144 125 16 1.1k
Tamara C. Murphy United States 22 802 1.3× 273 1.2× 95 0.7× 53 0.4× 162 1.3× 28 1.4k
Frederick Pfister Germany 21 593 0.9× 289 1.3× 118 0.8× 47 0.3× 167 1.3× 43 1.8k
Noël Lamandé France 21 865 1.3× 136 0.6× 104 0.7× 94 0.7× 133 1.1× 38 1.6k
Sergio Estrada Sweden 19 500 0.8× 180 0.8× 63 0.4× 66 0.5× 88 0.7× 47 1.1k
Adam J. Belanger United States 17 594 0.9× 117 0.5× 145 1.0× 51 0.4× 89 0.7× 25 1.2k
Clément E. Tagoe United States 18 623 1.0× 167 0.8× 135 0.9× 45 0.3× 108 0.9× 39 944
Hiroshi Koriyama Japan 22 596 0.9× 80 0.4× 69 0.5× 87 0.6× 218 1.7× 41 1.1k
Anne F. Buckley United States 19 538 0.8× 158 0.7× 50 0.3× 171 1.2× 214 1.7× 52 1.5k
Rosa Aledo Spain 20 507 0.8× 112 0.5× 66 0.5× 85 0.6× 103 0.8× 36 882
Matina Economopoulou Germany 14 363 0.6× 180 0.8× 84 0.6× 177 1.2× 346 2.8× 21 1.1k

Countries citing papers authored by Andreea O. Lungu

Since Specialization
Citations

This map shows the geographic impact of Andreea O. Lungu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreea O. Lungu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreea O. Lungu more than expected).

Fields of papers citing papers by Andreea O. Lungu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreea O. Lungu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreea O. Lungu. The network helps show where Andreea O. Lungu may publish in the future.

Co-authorship network of co-authors of Andreea O. Lungu

This figure shows the co-authorship network connecting the top 25 collaborators of Andreea O. Lungu. A scholar is included among the top collaborators of Andreea O. Lungu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreea O. Lungu. Andreea O. Lungu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Ifteni, Petru, et al.. (2025). Pre- and Post- COVID-19 Pandemic Pneumonia Rates in Hospitalized Schizophrenia Patients. Medicina. 61(7). 1251–1251. 1 indexed citations
2.
Muntean, Laura, Andreea O. Lungu, Alexandra Crăciun, et al.. (2016). Elevated Serum Levels of Sclerostin are Associated with High Disease Activity and Functional Impairment in Patients with Axial Spondyloarthritis. Clinical Laboratory. 62(04/2016). 589–97. 17 indexed citations
3.
Christensen, John D., Andreea O. Lungu, Elaine Cochran, et al.. (2014). Bone Mineral Content in Patients With Congenital Generalized Lipodystrophy Is Unaffected by Metreleptin Replacement Therapy. The Journal of Clinical Endocrinology & Metabolism. 99(8). E1493–E1500. 36 indexed citations
4.
Guettier, Jean‐Marc, et al.. (2013). The Role of Proinsulin and Insulin in the Diagnosis of Insulinoma: A Critical Evaluation of the Endocrine Society Clinical Practice Guideline. The Journal of Clinical Endocrinology & Metabolism. 98(12). 4752–4758. 32 indexed citations
5.
Lungu, Andreea O., Elaine Cochran, Rebecca J. Brown, et al.. (2013). The liver diseases of lipodystrophy: The long-term effect of leptin treatment. Journal of Hepatology. 59(1). 131–137. 121 indexed citations
6.
Lungu, Andreea O., et al.. (2012). Insulin Resistance Is a Sufficient Basis for Hyperandrogenism in Lipodystrophic Women With Polycystic Ovarian Syndrome. Obstetrical & Gynecological Survey. 67(9). 549–550. 1 indexed citations
7.
Lungu, Andreea O., et al.. (2011). Insulin Resistance Is a Sufficient Basis for Hyperandrogenism in Lipodystrophic Women with Polycystic Ovarian Syndrome. The Journal of Clinical Endocrinology & Metabolism. 97(2). 563–567. 39 indexed citations
8.
Lungu, Andreea O., et al.. (2011). Pentacyanido(L)ferrate(III) complexes: Crystal structures, electrochemical and DFT studies (L=pyrazine, 4,4′-bipyridine, azide). Polyhedron. 31(1). 539–547. 9 indexed citations
9.
Lupsa, Beatrice, Vandana Sachdev, Andreea O. Lungu, Douglas R. Rosing, & Phillip Görden. (2010). Cardiomyopathy in Congenital and Acquired Generalized Lipodystrophy. Medicine. 89(4). 245–250. 64 indexed citations
10.
Malek, Rana, Beatrice Lupsa, Andreea O. Lungu, et al.. (2010). Treatment of Type B Insulin Resistance: A Novel Approach to Reduce Insulin Receptor Autoantibodies. The Journal of Clinical Endocrinology & Metabolism. 95(8). 3641–3647. 67 indexed citations
11.
Lungu, Andreea O., et al.. (2009). EVOLUTIONAL MORPHOLOGY OF THE UMBILICAL CORD IN THE PERINATAL LIFE TIME IN CALVES. Lucrari Stiintifice - Universitatea de Stiinte Agricole a Banatului Timisoara, Medicina Veterinara. 42(2). 331–337. 1 indexed citations
12.
Marx, Stephen J., et al.. (2009). Multiple angiofibromas and collagenomas in a 45-year-old man with recurrent nephrolithiasis, fatigue, and vision loss. Journal of the American Academy of Dermatology. 61(2). 319–322. 3 indexed citations
13.
Lungu, Andreea O., Zheng‐Gen Jin, Hideyuki Yamawaki, et al.. (2004). Cyclosporin A Inhibits Flow-mediated Activation of Endothelial Nitric-oxide Synthase by Altering Cholesterol Content in Caveolae. Journal of Biological Chemistry. 279(47). 48794–48800. 65 indexed citations
14.
Tanimoto, Tatsuo, Andreea O. Lungu, & Bradford C. Berk. (2004). Sphingosine 1-Phosphate Transactivates the Platelet-Derived Growth Factor β Receptor and Epidermal Growth Factor Receptor in Vascular Smooth Muscle Cells. Circulation Research. 94(8). 1050–1058. 97 indexed citations
15.
Jin, Zheng‐Gen, Andreea O. Lungu, Liang Xie, et al.. (2004). Cyclophilin A Is a Proinflammatory Cytokine that Activates Endothelial Cells. Arteriosclerosis Thrombosis and Vascular Biology. 24(7). 1186–1191. 191 indexed citations
16.
Jin, Zheng‐Gen, Hiroto Ueba, Tatsuo Tanimoto, et al.. (2003). Ligand-Independent Activation of Vascular Endothelial Growth Factor Receptor 2 by Fluid Shear Stress Regulates Activation of Endothelial Nitric Oxide Synthase. Circulation Research. 93(4). 354–363. 313 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tamara C. Murphy Breakdown of academic impact, for papers by Frederick Pfister Breakdown of academic impact, for papers by Noël Lamandé Breakdown of academic impact, for papers by Sergio Estrada Breakdown of academic impact, for papers by Adam J. Belanger Breakdown of academic impact, for papers by Clément E. Tagoe Breakdown of academic impact, for papers by Hiroshi Koriyama Breakdown of academic impact, for papers by Anne F. Buckley Breakdown of academic impact, for papers by Rosa Aledo Breakdown of academic impact, for papers by Matina Economopoulou
Rankless by CCL
2026